Welcome to our dedicated page for Aurora Cannabis SEC filings (Ticker: ACB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aurora Cannabis Inc. filings document its U.S. reporting as a Canadian foreign private issuer and the formal disclosure record for its medical cannabis operations. Recent Form 6-K reports furnish news releases, material change reports, sales agreements and offering documents tied to product launches, financial results, acquisitions, governance matters and capital-structure activity.
The filings include disclosure for an at-the-market common-share program under shelf registration documents, material change reports on corporate transactions, and exhibits incorporated by reference into Form F-10 and Form S-8 registration statements. They also record Aurora's operating updates across regulated cannabis markets, GMP-certified manufacturing network, shareholder voting matters and executive-level governance disclosures.
Aurora Cannabis Inc. (ACB) has furnished a routine Form 6-K with the U.S. SEC dated 19 June 2025. The filing’s sole purpose is to transmit Exhibit 99.1, identified as a "News release dated June 19, 2025." No financial statements, operational metrics, or transactional details accompany the submission. The document simply confirms that the Company continues to report under Form 40-F and is signed by CEO Miguel Martin. Because the actual news release is not included in the provided content, investors receive no new quantitative or strategic information from this 6-K alone.
Overview: Aurora Cannabis Inc. (ACB) filed a Form 6-K for the month of June 2025.
The filing is purely procedural and furnishes Exhibit 99.1—a news release dated 18 June 2025—without reproducing the release’s contents. No financial statements, earnings figures, or strategic transaction details are included. The cover page confirms that the company continues to file annual reports under Form 40-F and that Chief Executive Officer Miguel Martin signed the submission on 18 June 2025.
Investor takeaway: Because the underlying press release is not provided, this 6-K offers no quantitative data or substantive operational updates. It should therefore be viewed as routine compliance rather than a market-moving disclosure.
Overview: Aurora Cannabis Inc. (ACB) filed a Form 6-K for the month of June 2025.
The filing is purely procedural and furnishes Exhibit 99.1—a news release dated 18 June 2025—without reproducing the release’s contents. No financial statements, earnings figures, or strategic transaction details are included. The cover page confirms that the company continues to file annual reports under Form 40-F and that Chief Executive Officer Miguel Martin signed the submission on 18 June 2025.
Investor takeaway: Because the underlying press release is not provided, this 6-K offers no quantitative data or substantive operational updates. It should therefore be viewed as routine compliance rather than a market-moving disclosure.